Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes. [electronic resource]
Producer: 20130827Description: 280-9 p. digitalISSN:- 2567-689X
- Anti-Inflammatory Agents -- pharmacology
- Cyclic AMP -- metabolism
- Cyclic GMP -- metabolism
- Dipyridamole -- pharmacology
- Dose-Response Relationship, Drug
- Down-Regulation
- Humans
- I-kappa B Proteins -- metabolism
- Inflammation Mediators -- metabolism
- Matrix Metalloproteinase 9 -- genetics
- Monocytes -- drug effects
- NF-KappaB Inhibitor alpha
- RNA, Messenger -- metabolism
- Signal Transduction -- drug effects
- Time Factors
- Tissue Inhibitor of Metalloproteinase-1 -- metabolism
- Transcription Factor AP-1 -- metabolism
- Transcription Factor RelA -- metabolism
- Tumor Necrosis Factor-alpha -- metabolism
- U937 Cells
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.